Systems-based digital twins to help characterize clinical dose-response and propose predictive biomarkers in a Phase I study of bispecific antibody, mosunetuzumab, in NHL.
Susilo ME, Li CC, Gadkar K · Clinical and translational science · 2023 · Article
10.1111/cts.13501
Verified evidence
Bibliographic record.